Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01465555 · ClinicalTrials.gov registry record · Phase 1
Evaluation of Web-Based Recovery Monitoring With Clinical Alerts
A Phase 1 study, sponsored by Treatment Research Institute.
- Completed
- Registry status
- Phase 1
- Development phase
- 389
- Enrollment target
NCT01465555: Completed Phase 1 study, sponsored by Treatment Research Institute.
NCT01465555 is a Phase 1 study that has completed, run by Treatment Research Institute. The registered enrollment target is 389 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (548% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01465555, a Phase 1 study, has completed, sponsored by Treatment Research Institute.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 389 participants
- Enrollment target
Study Summary
The specific aims of the project are to conduct a three-phase study to develop a data-driven Clinical Alert feature to the RecoveryTrack™ Concurrent Recovery Monitoring (CRM) system and test its efficacy, as follows: Phase I - Analyze RecoveryTrack and outcomes data to create a clinical algorithm that predicts early treatment attrition; adapt elements of a cognitive behavioral intervention (CBI) for use in addressing Clinical Alerts, as well as adapting training and adherence measures; reprogram RecoveryTrack with a Clinical Alert feature for each of the first three monitoring assessments to inform counselors when a client is at High Risk to leave treatment. Phase II -Conduct a feasibility trial to refine Clinical Alerts + CBI intervention and the study measures/procedures. Phase III - Conduct a pilot randomized clinical trial comparing outcomes of clients whose counselors were randomized to Clinical Alerts + CBI to those of clients whose counselors were assigned to TAU (control condition). The primary hypothesis is that clients who evidence a High Risk for attrition will have longer lengths of stay in the Clinical Alerts + CBI condition than High Risk clients in the control condition. Secondary client hypotheses are that High Risk clients in the Clinical Alert + CBI condition will attend more treatment sessions, have more drug-free urine results, and receive more ancillary services than High Risk clients in the control condition.
Primary Outcome
Client admission and discharge dates will be obtained from the treatment program clinical record and used to calculate length of stay.
Interventions
- BEHAVIORAL Cognitive Behavioral Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 389 participants |
| Start Date | 2010-01 |
| Est. Completion | 2013-12 |
| Phase | Phase 1 |
What the finished NCT01465555 record still lists
NCT01465555 is an interventional study that assigns participants to a tested intervention. The registered 389 participants enrollment target is mid-sized for trials with a published cap, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (548% higher).
The record links to 0 conditions, and to 1 intervention - of which Cognitive Behavioral Intervention is the first listed.
NCT01465555 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01465555 about?
NCT01465555 is a clinical study titled "Evaluation of Web-Based Recovery Monitoring With Clinical Alerts". The specific aims of the project are to conduct a three-phase study to develop a data-driven Clinical Alert feature to the RecoveryTrack™ Concurrent Recovery Monitoring (CRM) system and test its efficacy, as follows: Phase I - Analyze RecoveryTrack and outcomes data to create a clinical algorithm t...
What is the current status of trial NCT01465555?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 389 participants. The study started on 2010-01. Estimated completion is 2013-12.
What interventions are being tested in trial NCT01465555?
The interventions under investigation include: Cognitive Behavioral Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT01465555?
This trial is sponsored by Treatment Research Institute, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01465555's enrollment target sits among peer trials
389 79th of 2000 higher than 1,922 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05431088 · 389 participants · Phase 2
A Phase 2/3 Study in Adult and Adolescent Participants With SCD
- NCT00397111 · 390 participants
Development of Magnetic Resonance Imaging Techniques for Studying Mood and Anxiety Disorders
- NCT05335928 · 390 participants · Phase 3
Abatacept in Immune Checkpoint Inhibitor Myocarditis
- NCT05445960 · 390 participants · NA
Correlation Between Intraoperative Tourniquet Use and Limb pH, Functional Measures and Patient-reported Outcomes After Ankle Fracture Surgery
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia